COVID-19, Opportunities and benefits for cancer care Quality of Life 10. 01. 2022 What are the opportunities and benefits of COVID-19 for cancer care? COVID-19 brought Telemedicine and Tele-Oncology to Cancer. See the article https://mycancer.gr/news/post/covid-and-cancer. We communicate with our doctor remotely and report our symptoms promptly, so that we can receive early and effective treatment. Do you receive chemotherapy or radiotherapy? Visit CureCancer - mycancer.gr. Find the doctor that you need and communicate with him. Save your time, reduce your visits to the hospital and your expenses. A study showed an increase in quality of life, a reduction in hospital visits and a sense of security for patients. The online "relationship" of oncology patients with their doctors works like medicine, according to another study. For which patients is Tele-Oncology suitable? Tele-oncology is suitable for patients who (a) are regularly monitored, (b) are receiving oral chemotherapy and (c) are in need of supportive care services. CureCancer - mycancer.gr offers safe and easy communication with your doctor, remotely. You reduce the risk of infection, and have more time with your family! CureCancer - mycancer.gr can help us live better and longer! Tags: telemedicine , covid , chemotherapy , radiotherapy
Medication-Related Osteonecrosis of the Jaw in Cancer Therapy Events, Seminars, & Publications 13. 02. 2026 On April 2, mycancer invites you to another online seminar focusing on one of the most critical issues in modern Oncology:WEBINAR“Medication-Related Osteonecrosis of the Jaw in Cancer Therapy”Teaching...[Read more]
Osteonecrosis of the Jaws in Cancer Medications Events, Seminars, & Publications 04. 11. 2025 Following the success of the mycancer Online Seminar Series, we are pleased to invite you to the 4th WEBINAR “Osteonecrosis of the Jaws in Cancer Medications” of the 2025 series.Our goal is to promote...[Read more]
Medication-Related Osteonecrosis of the Jaw (MRONJ): From Theory to Practice – Advanced Training Webinar Events, Seminars, & Publications 28. 01. 2026 The Next Step in Managing Patients on Antiresorptive MedicationsOn January 16, 180 dentists attended our first webinar on MRONJ and risk assessment.The response was immediate:“The STEPS and their eval...[Read more]
